XtremeProPeptide, founded in 2007, is one of the original peptide companies in an industry saturated with young, inexperienced suppliers. It is our core values of delivering the highest quality, competitively priced products paired with an unsurpassed level of customer service that have enabled our company to thrive for several years.
(Growth hormone releasing peptide-2 )
Growth hormone releasing peptides or peptides stimulate endogenous growth hormone secretion
Growth hormone releasing peptides (GHRP-2, GHRP-6 and Hexarelin) is a small family of peptides that act on the pituitary and hypothalamus to release growth hormone (GH). These peptides were discovered 20 years ago and clinical studies have shown to be able to stimulate the pituitary gland to produce endogenous growth hormone.
Growth hormone releasing peptide-2 (GHRP-2)
Growth hormone releasing peptide-2 (GHRP-2) is a peptide consisting of only six amino acids, which stimulates the secretion of endogenous GH. In surveys, GHRP-2 demonstrated the ability to stimulate the pituitary gland to increase the secretion of GH 7-15 times, to stimulate ghrelin receptors and a way to promote appetite.
According to the results of the clinical trial, which were published in The Journal of Endocrinology and Metabolism in 1997, GHRP-2 increases the secretion of growth hormone in both adults and children, even in the elderly.
The main effects of GHRP-2 is GH stimulation of secretion, the promotion of appetite, increased fat mass and reduced muscle mass, reducing the level of cholesterol, skin and bone condition is improving, protection of the liver, and anti-inflammatory activity.
The investigations confirmed high security GHRP-2 and almost no side effects, if GHRP-2 is administered within the recommended dose range. GHRP-2 has been clinically tested for 30 years. This has delayed effects can be excluded.
The GHRP is a small family of peptides that act on the pituitary and hypothalamus to release growth hormone (GH) by the activation of a specific, G protein-coupled receptor.
They discovered 20 years ago as synthetic metenkephalin- derived oligopeptides (Synthetic tissue derived amino acids). Although no structural homology with growth hormone releasing hormone (GHRH), in clinical trials GHRP-2 showed activity in the pituitary gland to release human growth hormone (HGH). Similar results were effective when GHRP-2 was administered sublingually. Clinical studies have shown the most potent GHRP is the hexapeptide GHRP-2.
Growth hormone releasing peptide 2 (GHRP2) induces a significantly increased natural production in the pituitary gland of the own endogenous human growth hormone in the body (HGH). This therapy consisting of daily periodic dosage sublingual. Growth hormone releasing peptide 2, GHRP2 showed itself to dynamically increase the levels of IGF-1, and even appeared greater effects when used with growth hormone releasing hormone (GHRH), which also stimulates the pituitary gland to increase the natural secretion human growth hormone. This also enhances the function of the hypothalamus as well.
The increase of growth hormone in the body through IGF-1 increased levels produced by the pituitary gland in response to treatment GHRP2 – has an anabolic effect on body tissues and other benefits identified below.
The benefits of adult treatment GHRP2
GHRP2 release of growth hormone therapy peptide2 considered one of the few medical means to counter the effects of aging in adults with growth hormone deficiency. This is because the benefits of increased arousal and secretion of human growth hormone from the hypothalamus, pituitary, HPA.
All products listed and provided through Xtremepro Peptides.com are intended for research purposes only. We do not promote the personal use of these products. Products provided by Xtremepro Peptides.com are not intended for use in food products or as any type of drug. Our products are not intended to treat, prevent, mitigate or cure any disease or medical condition.